Bellberry provides the following documents relating to applications that involve radiation: BA G13 Ionising Radiation This guidance outlines the requirements […]
Learn more...AusMedTech 2021
14/05/2021
AusMedtech 2021: Reimagine and reconnect provides a week of virtual half-day sessions that represent Australia’s medtech industry; celebrate the successes […]
Learn more...2021 AAHRPP Annual Conference
13/05/2021
The AAHRPP annual conference will take place from May 18 to May 20. Join Kylie Sproston, Bellberry CEO, and Dr. […]
Learn more...Site-specific clauses document update
05/05/2021
Bellberry has updated the site-specific clauses document (BA F1.1.12) to include examples and a pre-submission checklist. Please note the following: […]
Learn more...Process changes at Bellberry
26/03/2021
It is now several months since Bellberry updated its procedures and we are pleased to report that there has been […]
Learn more...Viertel Senior Medical Research Fellowship and Clinical Investigator awards
18/03/2021
The Trustees of the Sylvia and Charles Viertel Charitable Foundation are pleased to announce two classes of research grants to […]
Learn more...Australian Showcase: clinical trials and medical innovation advantages
23/12/2020
AusBiotech invites you to its virtual showcase highlighting Australia’s clinical trial and medical innovation advantages, coinciding with the annual JP […]
Learn more...ACTA Summit and Clinical Trials 2020 National Tribute and Award Ceremony
26/11/2020
The ACTA Summit 2020 will be a ‘virtual’ gathering of Australian and international experts to discuss the design and conduct […]
Learn more...PRAXIS Australia: Early Phase Trials in Australia
11/11/2020
Bio Connections Australia: Virtual Event
09/11/2020
Bio Connections Australia explores drug development, early phase clinical trials, translational research and expediting Australia’s great science into commercialization. It […]
Learn more...COSA’s Annual Scientific Meeting
04/11/2020
In 2020 COSA are moving away from their tradition of focussing on one or two cancers, and featuring Quality & […]
Learn more...Batch submissions
01/09/2020
As part of our continuous improvement process, Bellberry has introduced a Batch Processing pathway. This pathway aims to ease the […]
Learn more...CT:IQ: Supporting the Implementation of eConsent in Australia
28/08/2020
CT:IQ is pleased to launch a series of use cases illustrating successful implementation of eConsent in Australia, aimed to be used […]
Learn more...eProtocol Registrations Change
14/08/2020
Bellberry is committed to ensuring the privacy and security for users of our service. In light of recent government announcements […]
Learn more...PRAXIS Webinar: What does the new face of Clinical Trials look like?
28/07/2020
Disruption, adaption and adoption The COVID-19 pandemic has rapidly transformed much of the clinical trials and associated medical device, pharmaceutical, […]
Learn more...COVID-19 FAQ
09/06/2020
COVID-19 FAQ As Bellberry’s position has changed significantly since 2020, please direct your COVID-19 queries to [email protected]. We’re here to […]
Learn more...Beyond COVID-19: A solution focussed forum
19/05/2020
ACTA, PRAXIS, ARCS and CT:IQ collaborate to host clinical trials online forum launching on International Clinical Trials Day, 20 May 2020 […]
Learn more...Challenges in valuing and paying for combination regimens in oncology
08/05/2020
Report of an international workshop convened by Bellberry, held on November 18-20, in Sydney, Australia In November 2019 Bellberry were […]
Learn more...Bellberry CEO joins ARCS COVID-19 Webinar
23/04/2020
Earlier this week Bellberry CEO Kylie Sproston joined Tam Nguyen (St Vincent’s Hospital Melbourne) and James Cokayne (NSW Health) to […]
Learn more...PRAXIS Australia free webinar series: Resilience in the era of COVID-19
ENROL NOW! PRAXIS’s small team has received over 1000 enrolments for these sessions and as such processing of registrations may […]
Learn more...